Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Breast Neoplasms 139Neoplasms 118Prostatic Neoplasms 64Lung Neoplasms 48Head and Neck Neoplasms 46Colorectal Neoplasms 38Ovarian Neoplasms 33Uterine Cervical Neoplasms 29Endometrial Neoplasms 23Motor Activity 22Neoplasm Metastasis 20Multiple Myeloma 20Pancreatic Neoplasms 19Brain Neoplasms 19Rectal Neoplasms 18Lymphoma 17Colonic Neoplasms 17Pain 16Gastrointestinal Neoplasms 16Fatigue 16Carcinoma, Non-Small-Cell Lung 16Leukemia 15Depression 15Oropharyngeal Neoplasms 13Melanoma 13Anxiety Disorders 13Urinary Bladder Neoplasms 12Hematologic Neoplasms 12Esophageal Neoplasms 12Stomach Neoplasms 11

Interventions

Oxaliplatin 6Irinotecan 5Fluorouracil 5Drug Therapy 4Bevacizumab 4Magnetic Resonance Spectroscopy 3Leucovorin 3Capecitabine 35,10-methylenetetrahydrofolic acid 3pembrolizumab 2Ocoxin 2Levoleucovorin 2Folfox protocol 2Exercise Test 2Cyclophosphamide 2Cetuximab 2trifluridine tipiracil drug combination 1sintilimab 1repotrectinib 1pralsetinib 1penpulimab 1napabucasin 1lutetium Lu 177 dotatate 1huachansu 1guadecitabine 1golotimod 1encorafenib 1copper dotatate CU-64 1alectinib 1XELOX 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Diseases × Surveys and Questionnaires × Clear all
NCT00867477 2014-08-28

PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide

M.D. Anderson Cancer Center

Phase 2 Completed
163 enrolled
GastrointestinalThoracic

Esophageal Neoplasms, Gastrointestinal Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡